India vs Pakistan: Hepatitis B surface antigen (HBsAg) prevalence
India
0.2%
in 2024
Pakistan
0.2%
in 2024
India rank
82nd
Pakistan rank
82nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- India
- Pakistan
How they compare
India currently reports 0.2% against 0.2% in Pakistan, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was India ahead.
India ranks 82nd and Pakistan ranks 82nd of 194 countries.
Across the 2 decades both report, India averaged higher in 1 and Pakistan in 1.
Head to head by decade
| Decade | India | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.3% | 0.1% | India |
| 2020s | 0.2% | 0.2% | 0.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, India or Pakistan?
- India, at 0.2% against 0.2% in Pakistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between India and Pakistan?
- 0.0%, with India ahead.
- How many years of comparable data are there for India and Pakistan?
- 10 years are reported by both, from 2015 to 2024.
- How do India and Pakistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- India ranks 82nd and Pakistan ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.